Abstracts Archive - Page 1215 of 2607 - ACR Meeting Abstracts

Abstract Number: 429 • 2018 ACR/ARHP Annual Meeting
The Potential Clinical Relevance of Imaging Biomarker Data from Short-Term Interventional Trials in Osteoarthritis: A Comparison of the Cathepsin K Inhibitor Miv-711 Phase 2a MRI Knee Joint Data and KL-Matched 5577 Knee Control Data from the Osteoarthritis Initiative
Philip G. Conaghan¹, Michael A Bowes², Sarah R. Kingsbury¹, Alan Brett², Gwenael Guillard², Åsa Jansson³, Cecilia Wadell³, Richard Bethell³ and John Öhd³, ¹Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, United Kingdom, Leeds, United Kingdom, ²Imorphics Ltd, Manchester, United Kingdom, ³Medivir AB, Huddinge, Sweden
Background/Purpose: New imaging biomarkers using supervised machine learning offer opportunities to demonstrate effects of potential DMOADs on joint structure in short, small trials based on…
Abstract Number: 430 • 2018 ACR/ARHP Annual Meeting
Prevalence of Intra-Articular Mineralization on Knee CT in Persons with or at Risk of Knee Osteoarthritis
Tuhina Neogi¹, John A. Lynch², Mohamed Jarraya³, Margaret M. Clancy¹, David T. Felson¹, Michael C. Nevitt⁴, Cora E. Lewis⁵, James Torner⁶ and Ali Guermazi⁷, ¹Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, ²University of California, San Francisco, San Francisco, CA, ³Musculoskeletal Radiology, Boston University School of Medicine, Boston, MA, ⁴Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, ⁵University of Alabama Birmingham, Birmingham, AL, ⁶University of Iowa, Iowa City, IA, ⁷Boston University School of Medicine, Boston, MA
Background/Purpose: While intra-articular (i.a.) mineralization can be visualized on knee radiographs, the sensitivity of its identification is low with this modality, hampering efforts to understand…
Abstract Number: 431 • 2018 ACR/ARHP Annual Meeting
Early Pre-Radiographic Structural Pathology Precedes the Onset of Accelerated Knee Osteoarthritis: Data from the Osteoarthritis Initiative
Matthew Harkey¹, Julie Davis², Bing Lu³, Lori Lyn Price^4,5, Robert J. Ward⁶, James MacKay⁷, Charles B. Eaton⁸, Grace H. Lo⁹, Mary Barbe¹⁰, Ming Zhang¹¹, Jincheng Pang¹², Alina Stout¹, Timothy E. McAlindon¹³ and Jeffrey B. Driban¹⁴, ¹Rheumatology, Tufts Medical Center, Boston, MA, ²Rheumatology, Tufts Medical Center, BOSTON, MA, ³Brigham & Women's Hospital and Harvard Medical School, Boston, MA, ⁴Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, ⁵Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, ⁶Radiology, Tufts Medical Center, Boston, MA, ⁷Radiology, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom, ⁸Family Medicine and Community Health( Epidemiology), Alpert Medical School of Brown University, Pawtucket, RI, ⁹Michael E. DeBakey Veterans Affairs Medical Center / Baylor College of Medicine, Houston, TX, ¹⁰Temple University School of Medicine, Philadelphia, PA, ¹¹Tufts Medical Center, Boston, MA, ¹²Electrical Engineering, Tufts University, Medford, MA, ¹³Division of Rheumatology, Tufts Medical Center, Boston, MA, ¹⁴Medicine, Division of Rheumatology, Tufts Medical Center, Boston, MA
Background/Purpose: Individuals that develop accelerated knee osteoarthritis (AKOA) have more frequent knee pain, decreased physical function, and are more likely to receive a knee replacement…
Abstract Number: 432 • 2018 ACR/ARHP Annual Meeting
Relation of Patellofemoral Joint Alignment, Morphology, and Radiographic Osteoarthritis to Frequent Anterior Knee Pain
Erin Macri¹, Tuhina Neogi², Irina Tolstykh³, Cora E. Lewis⁴, James Torner⁵, Michael C. Nevitt⁶ and Joshua J. Stefanik⁷, ¹Physical Therapy, University of Delaware, Newark, DE, ²Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, ³Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, ⁴University of Alabama Birmingham, Birmingham, AL, ⁵University of Iowa, Iowa City, IA, ⁶Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, ⁷Department of Physical Therapy, University of Delaware, Newark, DE
Background/Purpose: Radiographic patellofemoral osteoarthritis (OA) is prevalent in approximately 25% of population-based samples and 39% of individuals with knee pain. Discordance between knee OA features…
Abstract Number: 433 • 2018 ACR/ARHP Annual Meeting
Impact of Bariatric Surgery on Rheumatic Diseases: A Systematic Review and Meta-Analysis
Marie Moly¹, Bernard Combe¹, Thomas Barnetche², Claire Daien¹, Jacques Morel³, Cédric Lukas¹, Cécile Gaujoux-Viala⁴ and Charlotte Hua⁴, ¹Rheumatology, University Hospital Lapeyronie, Montpellier, Montpellier, France, ²Rheumatology, University Hospital Pellegrin, Bordeaux, Bordeaux, France, ³Department of Rheumatology, University Hospital Lapeyronie, Montpellier, Montpellier, France, ⁴Rheumatology, University Hospital Carémeau , Nimes, Nimes, France
Background/Purpose: Obesity increase the incidence of rheumatic diseases (1-3). Bariatric surgery (BS) improve obesity-related comorbidities (4). The aim of our study was to assess currently…
Abstract Number: 434 • 2018 ACR/ARHP Annual Meeting
Trends in Procedure Type, Patient Characteristics, and Outcomes Among Persons with Knee Osteoarthritis Undergoing Bariatric Surgery, 2005-2014
Yusi Gong¹, Faith Selzer², Bhushan Deshpande^1,3 and Elena Losina^1,4,5, ¹Orthopaedic and Arthritis Center for Outcomes Research, Department of Orthopedic Surgery, Brigham & Women's Hospital, Boston, MA, ²Orthopedic Surgery, Orthopedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, ³Harvard Medical School, Boston, MA, ⁴Orthopaedic Surgery, Harvard Medical School, Boston, MA, ⁵BU School of Public Health, Boston, MA
Background/Purpose: Bariatric surgery, the most effective treatment for losing weight and maintaining weight loss among morbidly obese persons, has been evolving as a treatment for…
Abstract Number: 435 • 2018 ACR/ARHP Annual Meeting
Is Frailty Associated with Worse Outcomes after Total Joint Replacements?
Lisa A. Mandl^1,2, Charles N. Cornell^3,4, Michael B. Cross^3,4, Alejandro Gonzalez Della Valle^3,4, Mark P. Figgie^3,4, Seth A. Jerabek^3,4, Justin Do⁵, Mayu Sasaki⁵, Nathaniel Hupert⁶, Jackie Szymonifka¹ and Steven K. Magid^7,8, ¹Hospital for Special Surgery, New York, NY, ²Medicine - Rheumatology, Weill Cornell Medicine, New York, NY, ³Surgery, Weill Cornell Medicine, New York, NY, ⁴Surgery, Hospital for Special Surgery, New York, NY, ⁵Quality Research Center, Hospital for Special Surgery, New York, NY, ⁶Medicine, Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, ⁷Medicine - Rhuematology, Hospital for Special Surgery, New York, NY, ⁸Medicine, Weill Cornell Medicine, New York, NY
Background/Purpose: To determine whether frailty is associated with clinical outcomes 1-year after total hip or total knee replacement, (TKR and THR). Methods: Community-dwelling patients ≥65yo…
Abstract Number: 436 • 2018 ACR/ARHP Annual Meeting
Structural Effects of Intra-Articular Sprifermin in Symptomatic Radiographic Knee Osteoarthritis: A Post-Hoc Analysis of Cartilage Morphology over the 2-Year Treatment-Period of a 5-Year Randomized, Placebo-Controlled, Phase II Study
Ali Guermazi¹, Jeffrey Kraines², Aida Aydemir², Stephen Wax³, Michel Crema⁴, Marc C. Hochberg⁵ and Frank Roemer^1,6, ¹Radiology, Boston University School of Medicine, Boston, MA, ²EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA, ³EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), BIllerica, MA, ⁴Boston University School of Medicine, Boston, MA, ⁵University of Maryland School of Medicine, Baltimore, MD, ⁶Department of Radiology, University of Erlangen-Nuremberg, Erlangen, Germany, Erlangen, Germany
Background/Purpose: Sprifermin, a recombinant human fibroblast growth factor 18, is currently being investigated as a potential disease-modifying OA drug. Sprifermin treatment leads to a dose-dependent…
Abstract Number: 437 • 2018 ACR/ARHP Annual Meeting
Does Reduction in Mechanical Knee Joint Loading Explain the Beneficial Effects of Weight Loss in Overweight or Obese Patients with Knee Osteoarthritis?
Dennis Ang¹, Daniel Beavers² and Stephen P. Messier³, ¹Wake Forest University School of Medicine, Winston-Salem, NC, ²Biostatistical Science, Wake Forest School of Medicine, WINSTON SALEM, NC, ³Department of Health and Exerc, Wake Forest University, Winston-Salem, NC
Background/Purpose: Knee osteoarthritis (KOA) is traditionally considered a local joint pathology. The effect of obesity on the pathogenesis of KOA is predominantly attributed to increase…
Abstract Number: 438 • 2018 ACR/ARHP Annual Meeting
What Characterizes Osteoarthritis: Ultrasound-Detected Inflammation but Not Osteophytes Is More Common in Hand Osteoarthritis Than in Painless Bony Enlargements
Nina Gasperi¹, Antonella Adinolfi², Arnd Kleyer³, Melanie Hagen³, Christiane Gasperi⁴, Martin Weger⁵, Stefan Kiechl⁶, Johann Willeit⁶, Georg Schett³, Annamaria Iagnocco⁷, Arno Gasperi⁸, Agnes Mayr⁹ and Christian Dejaco^10,11, ¹Medical University of Graz, Graz, Austria, Graz, Austria, ²Department of Medicine, surgery and Neurosciences, University of Siena, Siena, Italy, Siena, Italy, ³Department of Internal Medicine 3—Rheumatology and Immunology, Friedrich-Alexander-University Erlangen–Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, Germany, ⁴Department of Neurology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany, Munich, Germany, ⁵Department of Internal Medicine, Bruneck Hospital, Bruneck, Italy, Bruneck, Italy, ⁶Department of Neurology, Medical University of Innsbruck, Austria, Innsbruck, Austria, ⁷Academic Rhematology Center, University of Torino, Turin, Italy, Turin, Italy, ⁸Department of Neurology, Bruneck Hospital, Bruneck, Italy, Bruneck, Italy, ⁹Department of Laboratory Medicine, Bruneck Hospital, Italy, Bruneck, Italy, ¹⁰Rheumatology Service, South tyrolean Health trust, Hospital of Bruneck, Bruneck, Italy, Bruneck, Italy, ¹¹Department of Rheumatology and Immunology, Medical University Graz, Graz, Austria, Graz, Austria
Background/Purpose: To study structural and inflammatory ultrasound lesions in elderly subjects with hand osteoarthritis (HOA) as well as in pain-free subjects with bony enlargements of…
Abstract Number: 439 • 2018 ACR/ARHP Annual Meeting
Articular Cartilage from Osteoarthritis Patients Shows Extracellular Matrix Remodeling over the Course of Treatment with Sprifermin (Recombinant human fibroblast growth factor 18)
Ditte Reker¹, Christian S. Thudium², Anne Sofie Siebuhr³, Thorbjørn Gantzel⁴, Christoph Ladel⁵, Martin Michaelis⁵, Morten A. Karsdal², Anne Gigout⁵ and Anne C. Bay-Jensen², ¹Rheumatology, Nordic Bioscience, Biomarkers and Research, Herlev, Denmark, ²Nordic Bioscience, Herlev, Denmark, ³Biomarkers and Research, Nordic Bioscience, Herlev, Denmark, ⁴cOrthopedic Surgery Unit, Gentofte Hospital, Hellerup, Denmark, ⁵Merck KGaA, Darmstadt, Germany
Background/Purpose: Sprifermin, a truncated form of human fibroblast growth factor 18 (FGF18), is being investigated as a potential cartilage and disease-modifying OA drug. In vitro,…
Abstract Number: 440 • 2018 ACR/ARHP Annual Meeting
Assessing Inappropriate Pain Management in Adults with Hip or Knee Osteoarthritis Treated with Different Opioid Intensity Regimens: Results from a Retrospective Database Analysis
Nathaniel P. Katz^1,2, Kavita Gandhi³, Wenhui Wei⁴, Ahong Huang⁵ and Li Wang⁶, ¹President, Analgesic Solutions, Natick, MA, ²Tufts University School of Medicine, Boston, MA, ³Director, Global Health Economics and Outcomes Research, Teva Pharmaceutical Industries, Frazer, PA, ⁴Senior Director, Health Economics and Outcomes Research (HEOR), Regeneron Pharmaceuticals, Inc., Tarrytown, NY, ⁵Project Manager, STATinMED Research, Dallas, TX, ⁶Senior Director, Analytic Research, STATinMED Research, Dallas, TX
Background/Purpose: Opioids are often prescribed for osteoarthritis (OA) pain management despite the need for balancing their risks and benefits. Since there are no standard criteria…
Abstract Number: 441 • 2018 ACR/ARHP Annual Meeting
The Presence of Neuropathic Pain Does Not Influence the Response to Hyaluronic Acid (HA) in Patients with Knee Osteoarthritis but HA Injections Modify Pain Phenotype
Evariste Tiendrebeogo¹, Thierry Conrozier², Xavier Chevalier³ and Florent Eymard⁴, ¹Rheumatology, APHP Henri Mondor Hospital, Creteil, France, ²Department of Rheumatology,, Nord Franche-Comté Hospital, Belfort, France, ³Rheumatology, APHP Henri Mondor Hospital, Créteil, France, ⁴Department of Rheumatology, APHP Henri Mondor Hospital, Creteil, France
Background/Purpose: Twenty to forty percent of patients with symptomatic knee osteoarthritis (OA) described neuropathic pain (NP). Several studies have shown that hyaluronic acid (HA) is…
Abstract Number: 442 • 2018 ACR/ARHP Annual Meeting
Patient Factors Associated with Gaps in Osteoarthritis Care
Lauren King¹, Deborah A. Marshall² and Gillian Hawker³, ¹University of Toronto, Canada, Department of Medicine, University of Toronto, Toronto, ON, Canada, ²Community Health Sciences, University of Calgary, Calgary, AB, Canada, ³Women's College Research Institute/Women's College Hospital, Toronto, ON, Canada
Background/Purpose: Exercise, weight loss, simple analgesic medications and joint injections are effective non-surgical treatments for knee osteoarthritis (OA) to reduce pain and improve function. While…
Abstract Number: 443 • 2018 ACR/ARHP Annual Meeting
Impact of Intra-Articular Steroid Injection on Bone Marrow Lesions in Osteoarthritis of the Hip: An Assessment Using the Outcome Measures in Rheumatology Hip MRI Inflammation Scoring System
Walter P. Maksymowych^1,2, Robert G. Lambert³, Marcus Pianta⁴, Zeid Al-Ani⁵, Duncan Lindsay⁵, Ulrich Weber⁶, Susanne J Pedersen⁷, Stephanie Wichuk⁸, Kieran Steer⁹, Geoffrey Bostick¹⁰, Joel Paschke¹ and Jacob L. Jaremko¹¹, ¹CaRE Arthritis, Edmonton, AB, Canada, ²Medicine, Medicine, University of Alberta, Edmonton, AB, Canada, ³Department of Radiology & Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, ⁴Rheumatology, St. Vincent's Hospital, Melbourne, Australia, ⁵Radiology & Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, ⁶Department of Research, King Christian 10th Hospital for Rheumatic Diseases, Graasten, Denmark, ⁷Rheumatology, Gentofte Hospital, Copenhagen, Denmark, ⁸University of Alberta, Edmonton, AB, Canada, ⁹Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, ¹⁰Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, ¹¹Radiology, University of Alberta, Edmonton, AB, Canada
Background/Purpose: Intra-articular (I/A) steroid injection is an effective treatment for alleviating symptoms in osteoarthritis (OA) of the hip but the impact of this treatment on…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].